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Certain endogenous Xenopus mRNAs, carrying a destabilizing 3’AU-rich sequence, are unusually very stable in oocytes and become unstable only 
after fertilization. In addition, heterologous short lived mRNA, containing 3’ AU-rich sequences, appear to be very stable when injected into 
Xenopus oocytes. In the present study, a human interferon fi (hu-IFNB) mRNA, carrying the destabilizing 3’ AU-rich element, was used as a probe 
to identify Xenopus proteins that specifically bind to the 3’ AU-rich element as well as to study their relative levels during early embryonic 
development. While three major proteins that specifically bind to the 3’ AU-rich element were detected in human SV80 cells, that naturally express 
hu-IFNB (proteins termed AU-Fl, F2 and F3), only two proteins, migrating similarly to the SV80 AU-F1 and AU-F3, were detected in cytoplasmic 
extracts from Xenopus oocytes or eggs. Following fertilization, the intensity of the Xenopus AU-F1 and AU-F3 proteins increased considerably 
and a new protein, corresponding to SV80 AU-F2, was also detected. Cyclohexamide applied either at the morula or at the early blastula stages 
reduced the intensity of the AU-binding factors, while actinomycin D did not, indicating that the levels of these factors during these stages are 
regulated posttranscriptionally. In contrast, application of each of these metabolic inhibitors at the late blastula stage increased the intensity of 
the AU-binding proteins. The possible function of these AU-binding factors in regulating the expression and half life of AU-rich mRNAs is 
discussed. 
Human interferon p; AU-rich region; RNA-binding proteins; Xenopus luevis; Early embryogenesis; mRNA stability 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Many short lived mRNAs, including c-myc, c-j& and 
hu-II+@, share a common AU-rich sequence at their 3’ 
untranslated regions (UTR), which confer cytoplasmic 
instability [l-3]. Interestingly, during the reproductive 
stage of Xenopq these mRNAs appear to accumulate 
in oocytes and eggs and decreases ubstantially after 
fertilization [4-71. Even heterologous mRNAs contain- 
ing the destabilizing 3’ AU-rich element, like hu-IFNB, 
that turnover rapidly in their natural cells, are very 
stable upon injection into Xenopus oocytes. [8]. It was 
also suggested that Xenopus oocytes may lack some 
trans-acting factors that are necessary for the rapid 
turnover of these mRNAs [2]. 
Recent studies have identified several cytoplasmic 
proteins from a variety of eukaryotic cells that specifi- 
cally bind the 3’ AU-rich sequences of various mRNAs 
and may play a role in their translation and instability 
[9-131. In this study, we used hu-IFN@ mRNA as a 
probe to identify 3’ AU-binding activity in Xenopus 
oocytes and eggs as well as during the early embryonic 
development. Two specific AU-binding proteins were 
detected in oocytes and eggs, and an additional protein 
was detected only after fertilization. 
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2.1. Plasmids and enzymes 
The hu-IFNB constructs either carrying (#AllO) or lacking 
@/3AD79AllO) the AU-rich sequence as well as the constructs 
3;BAllO and 3’p79AllO (Fig. IA), used for studying the AU-binding 
activities, have been described previously [14]. Restriction endonu- 
cleases and T3 and T7 RNA polymerases were purchased from 
Boehringer Mannheim. 
2.2. Cell growth and preparation of cytoplasmic extracts 
Mature females of Xenopus laevis were injected into their dorsal 
lymphatic bags with 100 units of human chorionic gonadotropin 
(Pregnyl, Organon Holland) and 6 h later with a further 600 units. 
Ovulation of mature jellied eggs was induced 10-12 h after the second 
injection. Eggs were squeezed from the females onto 1 x MMR solu- 
tion (0.1 M NaCl, 2 mM KCl, 1 mM MgSO,, 2 mM CaCl,, 5 mM 
HEPES pH 7.8 and 0.1 mM EDTA) and fertilized by addition of 
sperm from macerated testes. Fertilized eggs were then dejellied by 
gentle swirling (5 min) in 2% cysteine freshly prepared in 0.1 x MMR 
solution, pH 7.8, followed by several washing with 0.1 x MMR. Em- 
bryos were then allowed to develop in 0.1 x MMR at room tempera- 
ture and staged as described by Nieuwkoop and Faber [15]. Samples 
were removed at various times during the early embryonic develop- 
ment, frozen by liquid nitrogen and stored at -80°C until used. 
Oocytes and embryos were homogenized in a solution containing 25 
mM Tris-HCl @H 7.8), 0.1 mM PMSF, 0.5 mM leupeptin and 0.5% 
NP-40, by pipetting up and down and centrifuged (14,000 x g, 4”C, 
10 min). The supernatant was collected and stored at -8O’C. Embryos 
at various stages of development were also incubated for one hour in 
0.1 x MMR solution containing 200 @ml cyclohexamide [16], or 
25 ,ug/ml actinomycin D. T’he embryos were then washed several times 
and allowed to develop up to the late gastrula stage. 
Human fibroblast SV80 cells [17], kindly provided by Dr. J. Che- 
bath (Dept. Molecular Genetics and Virology, The Weizmann Insti- 
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tute of Science, Rehovot, Israel), were grown to 80% confluence in 
Dulbecco modified Eagle medium supplemented with 5% fetal calf 
serum and 5% newborn calf serum at 37’C, 558% CO,. The cells were 
collected and washed twice in phosphate-buffered saline and lysed by 
freeze-thawing in 25 mM Tris-HCl @H 7.5) and 0.5% Nonidet P40. 
The homogenate was centrifuged at 14,000 x g for 10 min at 4”C, and 
the supernatant was collected and stored at -80°C until used. 
2.3. Analysis of mRNA stability in the oocytes 
In vitro transcription, injection of mRNAs into the oocytes, and 
maintenance of oocytes were as described 114, 181. Following micro- 
injection of approximately 2-5 ng of mRNA per oocyte, the oocytes 
were incubated in OR-2 medium [19] and sampled at various times 
after injection. Determination of RNA stability by RNase protection 
assay was performed essentially as previously described [20]. Ten pug 
of glycogen (Boehringer Mannheim) was used as a carrier instead of 
tRNA. 
2.4. UV cross-linking and label transfer 
Transfer of radioactivity from RNA probes to RNA-binding pro- 
teins was carried out as described previously [14]. The intensity of 
bands was analyzed by densitometry (Molecular Dynamics, 
Imagequant, USA). 
3. RESULTS 
In the present study, we used hu-IFNj? mRNA as a 
probe to identify specific proteins that bind to the 3’ 
AU-rich region and study their expression during 
oogenesis and early embryonic development of Xen- 
opus. We first wished to test whether hu-IFN/I will be 
stable in Xenopus oocytes, similarly to the endogenous 
Xenopus mRNAs containing the 3’ AU-rich region 
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Fig. 1. (A) Schematic representation of hu-IFN/I constructs employed in the present study. The RNA probes BBgl, 3’pAllO and 3’D79AllO, used 
to study AU-binding activity are indicated on the bottom. Symbols: Q coding region; 0 3’ UTR; I 3’ AU-rich sequence; Restriction enzymes: 
R = EcoRV, Ha = HaeIII, P = PstI, Bg = Bg/II, N = NdeI, H = HindIII. (B) The stability of PA1 10 and m79AllO mRNAs in Xenopus oocytes. 
Stability was analyzed by RNase protection at various times after injection as indicated on the top of the figure. Human/I-globin mRNA was injected 
with each mRNA as a reference. The specific protected fragments for hu-IFN/I and for /I-globin (#?Gm) mRNAs are indicated by arrows at left. 
c-IFN/I and c-/IGm are the protected fragments of noninjected /IAl 10 and /I-globin transcripts. The plasmid p5’/3 used for the protection assay 
of IFNB transcripts is presented below Fig. 1B. Pl indicates the “P-labeled probe complementary to the 5’ end of hu-IFN/l mRNA, while Pfl 
indicates the expected protected fragment. M indicates size markers of ‘*P-labeled MspI fragments of pBR322 with sizes in bp indicated at right. 
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Fig. 2. AU-binding activity in cytoplasmic extracts of human fibroblast SV80 cells and in Xenopw oocytes and eggs. Fifteen lug of total cytoplasmic 
proteins were mixed with 10 femtomoles of either AU’ (3’/3AllO) or AU- (3’D79AllO) RNA probes. After UV-cross linking and RNase treatment, 
the samples were subjected to electrophoresis on 10% polyacrylamide gel containing 0.1% SDS. Proteins were detected by autoradiography. HC 
indicates lOO-fold molar excess of the non radioactive homologous competitor, while NC indicates loo-fold molar excess of the non radioactive 
non homologous competitor, /3Bgl RNA. Specific complexes are indicated by arrows. The position of molecular weight markers is indicated at 
left. 
[4,5,6,7]. Two hybrid hu-IFN/? mRNAs, carrying the 
AU-rich region @Al 10) or lacking it Q3D79AllO) were 
transcribed in vitro, and each of them was coinjected 
into oocytes with an equal amount of globin mRNA as 
a reference. The stability of both mRNAs was assayed 
at various times after injection by RNase protection, 
using an antisense RNA probe corresponding to the 5’ 
end of hu-IFNB mRNA (illustrated at the bottom of 
Fig. 1B). Both mRNAs were equally stable in the 
oocytes for at least 44 h after injection (Fig. 1B). 
Since the 3’ AU-rich sequences of hu-IFN/I mRNA 
and of other short-lived messages have been shown to 
confer mRNA instability in the natural systems, we 
hypothesized that the unusual stability of such mRNAs 
in Xenopus oocytes may be due to low levels or absence 
of trans-acting factors which specifically bind to this 
region and are involved directly or indirectly in mRNA 
decay. Such factors should exist in mammalian cells and 
may be induced during early embryonic development of 
Xenopus. 
To test this hypothesis, we performed RNA binding 
assays by using the label transfer procedure [21]. The 
RNA probes, AU’ (3’BAllO) and AU- (3’D79Al lo), 
used for these experiments and the competitor RNA 
CgBgl) are shown schematically in Fig. 1A. The binding 
activity of the 3’AU-rich sequence was first tested in a 
cytoplasmic extract from oocytes and eggs. For com- 
parison, we used cytoplasmic extracts from SV80 
human fibroblast cells that naturally express IFN/3 and 
were previously shown to contain three AU-binding 
factors [14]. In order to select specifically for binding to 
the AU-rich sequence, the RNA was labeled with 
[cG~~P]UTP. Fig. 2, lane 1 shows that the AU’ probe 
(3’BAllO) transferred its radioactivity to proteins from 
SV80 cells to form three specific complexes (designated 
AU-Fl, AU-F2 and AU-F3, see arrows) that migrated 
between 33 to 46 kDa (see also [14]). Only very faint 
bands could be detected on the autoradiogram when the 
SV80 extract was incubated with the 3’D79AllO AU- 
probe (Fig. 2, lanes C6), implying that the proteins 
bound specifically to the AU-rich sequence. When the 
AU’ RNA probe was incubated with cytoplasmic ex- 
tracts from either Xenopus oocytes or eggs (Fig. 2, lanes 
7 and 10) only two specific complexes were detected that 
migrated similarly to the SV80 AU-F1 and AU-F3. 
However, the intensity of these bands was much lower 
than their corresponding bands from the SV80 cells. 
Again, no complexes could be detected when the oocyte 
extracts were incubated with AU- RNA probe (lanes 
13-l 5). The specificity of the protein-RNA interactions 
was also assessed by competition experiments (Fig. 2). 
One hundred-fold molar excess of unlabeled homolo- 
gous RNA (HC, AU+ RNA), strongly reduced AU- 
binding activity, while a lOO-fold molar excess of unla- 
beled non homologous RNA derived from BBgl (NC, 
AU- RNA) did not (Fig. 2, cf. lanes 2, 8 and 11 with 
lanes 3, 9 and 12, respectively). No complexes could be 
detected when the cytoplasmic extracts were preincu- 
bated with proteinase K (data not shown), indicating 
that binding activity involved protein factors. 
Next, we tested the developmental regulation of the 
AU-specific binding activity during early embryonic 
development of Xenopus. Following fertilization, the 
intensity of AU-F1 and AU-F3 increased until late gas- 
trula, which was the latest time tested (Fig. 3, cf. lanes 
l-3 with lanes 4-10). Densitometer tracing analysis esti- 
mated that the intensity of these proteins was increased 
by about 2.5-fold (data not shown). In addition, a new 
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Fig. 3. The AU-binding activity during early embryonic development of Xenopus. Fertilized eggs were allowed to develop in MMR medium and 
groups of 20 embryos were harvested at the indicated developmental stages. 15 pug of total cytoplasmic proteins were mixed with 10 femtomoles 
of the AU+ probe (3’pAl lo), and after UV-cross linking and RNase treatment, he samples were subjected to electrophoresis on 10% polyacrylamide 
gel containing 0.1% SDS. Proteins were detected by autoradiography. Specific complexes are indicated by arrows, while the position of molecular 
weight markers is indicated on the left. Lanes l-7 represent he respective AU-binding proteins from oocytes (0); one cell embryos (E); four cell 
embryos (EII); morula (M); early blastula (EB); late blastula (LB); and late gastrula (LG). Group of 20 embryos were also pretreated for 1 h with 
cyclohexamide (CHX) (lanes S-10) or with actinomycin D (ActD) (lanes 11-13) and allowed to develop to the late gastrula stage. Pretreatments 
were performed at the morula (lanes 8,ll); early blastula (lanes 9,12) and late blastula (lanes 10,13) stages. 
protein band, that migrated very similarly to the human 
AU-F2 protein, was detected after fertilization (Fig. 3, 
lanes 4-l 3). As the first 12 cell divisions following fertil- 
ization take place without transcription, the above re- 
sults suggested that during this period, the increased 
levels of the AU-binding proteins was apparently regu- 
lated posttranscriptionally. To address this, we tested 
the effect of the metabolic inhibitors cyclohexamide and 
actinomycin D on the expression of the AU-binding 
proteins. Embryos were pretreated for one hour with 
cyclohexamide or actinomycin D at the morula, early 
blastula or late blastula stages, and then allowed to 
develop into late gastrula and harvested. The level of all 
three proteins at late gastrula was slightly decreased 
when embryos were pretreated at the morula or early 
blastula with cyclohexamide, but not with actinomycin 
D (Fig. 3, cf. lanes 8, 9 and 11, 12). Interestingly, as 
shown in Fig. 3 lanes 10 and 13, treatment with each of 
these metabolic inhibitors at late blastula caused an 
about 2-fold increase in the intensity of the three AU- 
binding proteins (densitometer tracing data is not 
shown). 
4. DISCUSSION 
The observation that certain mRNAs containing a 
3’ AU-rich sequence, which generally turnover very rap- 
idly, appear to be very stable in Xenopus oocytes sug- 
gested that these unique cells may lack some trans-act- 
ing factors that are required for the rapid turnover of 
these mRNAs [2]. We have previously shown that 
human SV80 cells, which naturally produce hu-IFNB, 
contain three major proteins that specifically bind to the 
3’ AU-rich region of hu-IFNJ? mRNA [14]. In this work, 
we showed that similar proteins are also present in Xen- 
opus. This similarity indicates that AU-binding proteins 
are evolutionary conserved and supports previous ob- 
servations showing high conservation of RNA-protein 
complexes from frog to man [22]. 
Notably, only two of these AU-binding proteins 
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(AU-F1 and AU-F3) were detected at relatively low 
amounts in Xenopus oocytes and eggs where mRNAs 
containing 3’ AU-rich region are unusually stable. In- 
terestingly, following fertilization, when endogenous 
AU-rich mRNAs become unstable in Xenopus, the lev- 
els of AU-F1 and AU-F3 were elevated and AU-F2 was 
first detected in the gel. We can not yet discriminate 
whether AU-F2 is expressed only after fertilization or 
it is present in very low levels also in oocytes and eggs. 
Since new transcription in Xenopus embryos is de- 
tected only after the 12th cell division, at the midblas- 
tula transition [23], the increased binding activity of the 
three factors before midblastula is apparently regulated 
post-transcriptionally. This was indeed confirmed by 
our results showing that the level of these proteins was 
reduced upon treatment of the embryos with cyclohex- 
amide, but not actinomycin D before midblastula. In- 
terestingly, treatment with each of these metabolic in- 
hibitors at late blastula, when new transcription has 
already been established [23], caused a considerable in- 
crease in the intensity of all three proteins. Although the 
significance of this observation is yet unknown, it sug- 
gests that at late blastula there is active expression of 
genes whose protein products influence either the stabil- 
ity or the binding activity of these AU-binding factors. 
A similar observation was also previously reported 
showing that cyclohexamide increased the accumula- 
tion of two cytoplasmic factors in LpsnPM cells that are 
capable of interaction with the 3’ AU-rich sequence of 
hu-IFNB mRNA [24]. 
At the present, we can not be certain of the role of 
AU-Fl, AU-F2 and AU-F3 in the translation and insta- 
bility of AU-rich mRNAs. However, based on the 
correlation between the induction of these AU binding 
factors and the developmental regulation of mRNA 
destabilization, caused by the 3’ AU rich region [4- 
7,16,25], it is tempting to suggest that AU-F2, or all 
three AU- binding proteins are involved either directly 
or indirectly in this destabilization process. 
The mechanism of decay of the AU-rich mRNAs is 
Volume 336, number 3 FEBSLETT’ERS December 1993 
also unknown. Previous studies have shown that the 
AU-rich motif by itself is not necessary for mRNA 
degradation and that other regions located within the 
coding regions were found capable of conferring 
mRNA instability [26-283. The degradation of certain 
mRNAs, including that of IFNjI, was found to be cou- 
pled to their ongoing translation [29-311. Hence, the 
turnover of AU-rich mRNAs may also be indirectly 
influenced by factors that affect their translational ac- 
tivity. This hypothesis may be supported by several ines 
of evidence: (i) we have previously shown that the AU- 
rich ‘destabilizing’ region of hu-IFNB may inhibit its 
translation by iteracting with the 3’ poly(A) tail, sug- 
gesting a possible mechanism for concomitant activa- 
tion of both translation and destabilization of this 
mRNA by shortening of the poly(A) tail [14], (ii) in 
yeast, shortening of the poly(A) tail was suggested as a 
potential maturation step of mRNAs making them 
competent for efficient translation [32], and (iii) short- 
ening of the poly (A) tail of c-jiis mRNA was shown to 
be mediated by the 3’ AU-rich region [29]. Considering 
these observations, we can not exclude the possibility 
that the AU-specific binding proteins are involved in 
translational regulation of AU-rich mRNAs and by 
that indirectly affect mRNA turnover rate. Additional 
experiments are needed to unravel this important regu- 
latory mechanism. 
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